Precipio, Inc. PRPO
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- -22.58%
- 1 year
- -13.22%
- Open
- 18.48
- Prev close
- 18.10
- Mkt cap
- 31.85M
- Vol
- 12.78K
- Avg vol
- 105.58K
- EPS
- -0.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.79
- High
- 18.70
- Forward P/E
- 13.34
- Beta
- 1.42
- Short ratio
- 0.59
- Inst. own
- 8.79%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.13
- 200-d avg
- 5.98
- 1y target
- 0.00
News
5 days ago globenewswire.com
Precipio Announces Q3-2026 Shareholder Update Call
NEW HAVEN, Conn., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q3-2026 shareholder update call on November 10th, 2026, at…
1 week ago defenseworld.net
Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Here’s Why
Precipio, Inc. (NASDAQ: PRPO - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $25.20 and…
3 weeks ago seekingalpha.com
Precipio: Management Dreams Big, Institutions Have A Toe In
Precipio is an established laboratory services provider in cancer diagnostics and has launched a razor and razor blade model for facilities to test their own samples on site. 16.6% of the stock is…
3 weeks ago defenseworld.net
Precipio (NASDAQ:PRPO) Share Price Crosses Below 200 Day Moving Average – What’s Next?
Precipio, Inc. (NASDAQ: PRPO - Get Free Report)'s share price passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $25.53 and…
1 month ago zacks.com
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?
Precipio and Fulgent Genetics differ in business scope, valuation and growth drivers, but which cancer diagnostics stock looks more compelling now? Let's dive in.
1 month ago defenseworld.net
Analyzing Precipio (NASDAQ:PRPO) and AdaptHealth (NASDAQ:AHCO)
AdaptHealth (NASDAQ: AHCO - Get Free Report) and Precipio (NASDAQ: PRPO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses…
1 month ago benzinga.com
Precipio Q2 2026 Earnings Call: Complete Transcript
Precipio (NASDAQ:PRPO) held its second-quarter earnings conference call on Monday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive…
2 months ago zacks.com
PRPO vs. BDSX: Which Cancer Diagnostics Stock Is the Better Buy Now?
Precipio and Biodesix take different approaches to cancer diagnostics, but which stock looks more compelling now? Let's dive in.
2 months ago zacks.com
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong
PRPO's second-quarter 2026 revenue momentum strengthens on higher diagnostic volumes and record product sales, alongside positive adjusted EBITDA and cash generation.
2 months ago seekingalpha.com
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
Precipio, Inc. (PRPO) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
Precipio Q2 EPS $(0.12) Down From $0.05 YoY, Sales $7.021M Up From $5.654M YoY
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.12) per share. This is a 340 percent decrease over earnings of $0.05 per share from the same period last year. The company reported $7.021…
2 months ago globenewswire.com
Precipio Announces Q2-2026 Financial Results
Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and strengthens cash position Revenue reaches quarterly record as Precipio returns to positive Adjusted EBITDA and…
3 months ago defenseworld.net
Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average – Should You Sell?
Precipio, Inc. (NASDAQ: PRPO - Get Free Report) passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $25.12 and traded as low as $20.20.…
3 months ago globenewswire.com
Precipio Announces Q2-2026 Shareholder Update Call
NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17th, 2026, at…
3 months ago zacks.com
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy?
Precipio and NeoGenomics take different approaches to cancer diagnostics, but which oncology stock looks more compelling now? Let's dive in.
4 months ago globenewswire.com
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote…
4 months ago globenewswire.com
Precipio to Present at the Planet MicroCap Las Vegas
NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on…
5 months ago zacks.com
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and higher spending squeeze margins and widen losses.
5 months ago seekingalpha.com
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
Precipio, Inc. (PRPO) Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
Precipio Q1 EPS $(0.81) Down From $(0.59) YoY, Sales $6.711M Up From $4.929M YoY
Precipio (NASDAQ:PRPO) reported quarterly losses of $(0.81) per share. This is a 37.29 percent decrease over losses of $(0.59) per share from the same period last year. The company reported $6.711…
5 months ago globenewswire.com
Precipio Announces Q1 2026 Financial Results
Stable revenue performance driven by timing dynamics; expanding product pipeline expected to drive second-half growth Stable revenue performance driven by timing dynamics; expanding product pipeline…
5 months ago globenewswire.com
Management team’s 2025 market-based Options have vested
NEW HAVEN, Conn. , May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of…
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
8 months ago benzinga.com
Precipio Q4 2025 Preliminary Revenue $6.7M, An Increase Of 23% From $5.4M YoY
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaudited) financials for Q4-2025 and for its fiscal year 2025.Below are some of the key financial…
-
1 year ago benzinga.com
Precipio Q2 EPS $0.05 Up From $(0.83) YoY, Sales $5.654M Up From $4.441M YoY
Precipio (NASDAQ:PRPO) reported quarterly earnings of $0.05 per share. This is a 106.02 percent increase over losses of $(0.83) per share from the same period last year. The company reported $5.654…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
1 year ago benzinga.com
Precipio Revises Warrant Agreement With Largest Holder; 100K To Be Exercised For Cash, 200K Through Cashless Conversion
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
1 year ago benzinga.com
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
2 years ago benzinga.com
Precipio Announces The Launch Of A New Version Of Its Bloodhound MPN Panel That Is Now Able To Distinguish Between CALR Type 1 And Type 2 Mutations
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces the launch of a new version of its Bloodhound MPN (Myeloproliferative Neoplasm) panel that is now able to distinguish…
-
2 years ago benzinga.com
Precipio Reports $0.3M Cash Generated By Operations In Q2 2024
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the…
-
2 years ago benzinga.com
Precipio Reports Q2 2024 Revenue Of $4.4M Vs $4.33M Est; Expects Pathology Division's Revenues Will Reach More Than $1.5M Per Month By Year End
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one…
-
2 years ago benzinga.com
Precipio And Cardinal Health Sign Distribution Agreement For Its HemeScreen Portfolio Of Molecular Assays For Cancer
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces it has entered into a distribution agreement with Cardinal Health for its HemeScreen molecular assay products. Under the…
-
2 years ago benzinga.com
Precipio's Q4-2023 Cash Burn From Operations Drops Below $100K For The Full Quarter; Precipio's End Of Quarter Cash Balance Changed From ~$1.5M At The End Of Q3-2024, To ~$1.4M As Of Dec 31, 2023
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO) announces that continued revenue growth generated cash levels that bring the company closer to breakeven. Cash Burn From Operations…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During the session on Thursday, 461 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 175 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 59 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 54 companies hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 32 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 32 companies reached new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
During Thursday, 35 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 127 companies set new 52-week lows.